236 related articles for article (PubMed ID: 33309263)
1. Autofluorescence-guided surgery for the treatment of medication-related osteonecrosis of the jaw (MRONJ): a retrospective single-center study.
Otto S; Schnödt EM; Haidari S; Brunner TF; Aljohani S; Mosleh M; Ristow O; Troeltzsch M; Pautke C; Ehrenfeld M; Fliefel R
Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 May; 131(5):519-526. PubMed ID: 33309263
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence-guided surgery for the treatment of medication-related osteonecrosis of the jaw: A prospective cohort study.
Otto S; Ristow O; Pache C; Troeltzsch M; Fliefel R; Ehrenfeld M; Pautke C
J Craniomaxillofac Surg; 2016 Aug; 44(8):1073-80. PubMed ID: 27263757
[TBL] [Abstract][Full Text] [Related]
3. Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents.
Hauer L; Jambura J; Hrusak D; Chalupova M; Posta P; Rusnak S; Vyskocil V
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):100-107. PubMed ID: 30647474
[TBL] [Abstract][Full Text] [Related]
4. Is the conservative non-surgical management of medication-related osteonecrosis of the jaw an appropriate treatment option for early stages? A long-term single-center cohort study.
Ristow O; Rückschloß T; Müller M; Berger M; Kargus S; Pautke C; Engel M; Hoffmann J; Freudlsperger C
J Craniomaxillofac Surg; 2019 Mar; 47(3):491-499. PubMed ID: 30642734
[TBL] [Abstract][Full Text] [Related]
5. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
[TBL] [Abstract][Full Text] [Related]
6. Can Autofluorescence Guide Surgeons in the Treatment of Medication-Related Osteonecrosis of the Jaw? A Prospective Feasibility Study.
Giudice A; Bennardo F; Barone S; Antonelli A; Figliuzzi MM; Fortunato L
J Oral Maxillofac Surg; 2018 May; 76(5):982-995. PubMed ID: 29175416
[TBL] [Abstract][Full Text] [Related]
7. Can Surgical Management Improve Resolution of Medication-Related Osteonecrosis of the Jaw at Early Stages? A Prospective Cohort Study.
Giudice A; Barone S; Diodati F; Antonelli A; Nocini R; Cristofaro MG
J Oral Maxillofac Surg; 2020 Nov; 78(11):1986-1999. PubMed ID: 32615096
[TBL] [Abstract][Full Text] [Related]
8. Complementarity of Photo-Biomodulation, Surgical Treatment, and Antibiotherapy for Medication-Related Osteonecrosis of the Jaws (MRONJ).
Nica DF; Riviș M; Roi CI; Todea CD; Duma VF; Sinescu C
Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33562600
[No Abstract] [Full Text] [Related]
9. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
[TBL] [Abstract][Full Text] [Related]
10. Medication-related osteonecrosis of the jaw without osteolysis on computed tomography: a retrospective and observational study.
Sakamoto Y; Sawada S; Kojima Y
Sci Rep; 2023 Aug; 13(1):12890. PubMed ID: 37558709
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Stage 2 Medication-Induced Osteonecrosis of the Jaw: A Case Series.
Pardo-Zamora G; Martínez Y; Moreno JA; Ortiz-Ruíz AJ
Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33498884
[TBL] [Abstract][Full Text] [Related]
12. Surgical treatment of medication-related osteonecrosis of the upper jaw: Case series.
Aljohani S; Troeltzsch M; Hafner S; Kaeppler G; Mast G; Otto S
Oral Dis; 2019 Mar; 25(2):497-507. PubMed ID: 30325561
[TBL] [Abstract][Full Text] [Related]
13. Conservative surgical treatment of medication related osteonecrosis of the jaw (MRONJ) lesions in patients affected by osteoporosis exposed to oral bisphosphonates: 24 months follow-up.
Nisi M; Karapetsa D; Gennai S; Ramaglia L; Graziani F; Gabriele M
J Craniomaxillofac Surg; 2018 Jul; 46(7):1153-1158. PubMed ID: 29802059
[TBL] [Abstract][Full Text] [Related]
14. Medication-related osteonecrosis of the jaw in oncological patients with skeletal metastases: conservative treatment is effective up to stage 2.
Coropciuc RG; Grisar K; Aerden T; Schol M; Schoenaers J; Politis C
Br J Oral Maxillofac Surg; 2017 Oct; 55(8):787-792. PubMed ID: 28760314
[TBL] [Abstract][Full Text] [Related]
15. Retrospective Analysis of Treatment Outcomes of Maxillary Sinusitis Associated with Medication-Related Osteonecrosis of the Jaw.
Otsuru M; Hayashida S; Morishita K; Murata M; Soutome S; Sasaki M; Takagi Y; Sumi M; Umeda M
Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742679
[TBL] [Abstract][Full Text] [Related]
16. Comment on "Autofluorescence-guided surgery for the treatment of medication-related osteonecrosis of the jaw (MRONJ): a retrospective single-center study" by Otto et al. (May 2021).
Desai RS; Bansal SP; Shirsat PM; Dhanawade SS; Chavhan SU
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Jan; 133(1):118-119. PubMed ID: 34493471
[No Abstract] [Full Text] [Related]
17. Evaluation of surgical outcome and influencing risk factors in patients with medication-related osteonecrosis of the jaws.
Klingelhöffer C; Zeman F; Meier J; Reichert TE; Ettl T
J Craniomaxillofac Surg; 2016 Oct; 44(10):1694-1699. PubMed ID: 27591091
[TBL] [Abstract][Full Text] [Related]
18. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP
Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
[TBL] [Abstract][Full Text] [Related]
19. Sclerotic bone: a sign of bone reaction in patients with medication related osteonecrosis of the jaw.
Obermeier KT; Dewenter I; Malenova Y; Fliefel R; Kaeppler G; Otto S
Sci Rep; 2024 Apr; 14(1):7914. PubMed ID: 38575664
[TBL] [Abstract][Full Text] [Related]
20. Microarchitecture of medication-related osteonecrosis of the jaw (MRONJ); a retrospective micro-CT and morphometric analysis.
Schoenhof R; Munz A; Yuan A; ElAyouti A; Boesmueller H; Blumenstock G; Reinert S; Hoefert S
J Craniomaxillofac Surg; 2021 Jun; 49(6):508-517. PubMed ID: 33707134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
